RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0043-1777105
Sjogren's syndrome: a neurological perspective
Síndrome de Sjogren: uma perspectiva neurológica
Abstract
Sjogren's syndrome (SS) is a complex autoimmune disease characterized by lymphocytic infiltration of salivary and lacrimal glands, resulting in sicca symptoms. Additionally, SS presents with neurological manifestations that significantly impact the nervous system. This review aims to provide a comprehensive overview of the neurological aspects of SSj, covering both the peripheral and central nervous system involvement, while emphasizing diagnosis, treatment, and prognosis.
Resumo
A síndrome de Sjogren (SS) é uma doença autoimune complexa caracterizada pela infiltração linfocítica das glândulas salivares e lacrimais, resultando em sintomas sicca. Além disso, a SS apresenta manifestações neurológicas que afetam significativamente o sistema nervoso. Esta revisão tem como objetivo fornecer uma visão abrangente dos aspectos neurológicos da SSj, abordando tanto o envolvimento do sistema nervoso periférico quanto do central, com ênfase no diagnóstico, tratamento e prognóstico.
Authors' Contributions
OGPB, MPMM, PHAF, VHRM, AWSS, PBN, MS: contributed equally with the manuscript by helping to review and select papers; writing the first draft and the final versions of manuscript, and reviewing the manuscript.
Publikationsverlauf
Eingereicht: 18. August 2023
Angenommen: 20. Oktober 2023
Artikel online veröffentlicht:
29. Dezember 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Mavragani CP, Moutsopoulos HM. Sjögren's syndrome. Annu Rev Pathol 2014; 9 (01) 273-285
- 2 Seeliger T, Kramer E, Konen FF. et al. Sjögren's syndrome with and without neurological involvement. J Neurol 2023; 270 (06) 2987-2996
- 3 Ye W, Chen S, Huang X. et al. Clinical features and risk factors of neurological involvement in Sjögren's syndrome. BMC Neurosci 2018; 19 (01) 26
- 4 Perzyńska-Mazan J, Maślińska M, Gasik R. Neurological manifestations of primary Sjögren's syndrome. Reumatologia 2018; 56 (02) 99-105
- 5 Baer AN, Hammitt KM. Sjögren's Disease, Not Syndrome. Arthritis Rheumatol 2021; 73 (07) 1347-1348
- 6 Fox RI. Sjögren's syndrome. Lancet 2005; 366 (9482) 321-331
- 7 Ramos-Casals M, Brito-Zerón P, Seror R. et al; EULAR Sjögren Syndrome Task Force. Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 2015; 54 (12) 2230-2238
- 8 Baldini C, Pepe P, Quartuccio L. et al. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 2014; 53 (05) 839-844
- 9 Shiboski CH, Shiboski SC, Seror R. et al; International Sjögren's Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 2017; 69 (01) 35-45
- 10 Veenbergen S, Kozmar A, van Daele PLA, Schreurs MWJ. Autoantibodies in Sjögren's syndrome and its classification criteria. J Transl Autoimmun 2021; 5: 100138
- 11 Mori K, Iijima M, Koike H. et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005; 128 (Pt 11): 2518-2534
- 12 Grant IA, Hunder GG, Homburger HA, Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology 1997; 48 (04) 855-862
- 13 Perzyńska-Mazan J, Maślińska M, Gasik R. Neurological manifestations of primary sjögren's syndrome. Vol. 56, Reumatologia. Termedia Publishing House Ltd.; 2018: 99-105
- 14 Lopate G, Pestronk A, Al-Lozi M. et al. Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome. Muscle Nerve 2006; 33 (05) 672-676
- 15 Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology 2005; 65 (06) 925-927
- 16 Gono T, Kawaguchi Y, Katsumata Y. et al. Clinical manifestations of neurological involvement in primary Sjögren's syndrome. Clin Rheumatol 2011; 30 (04) 485-490
- 17 Berkowitz AL, Samuels MA. The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis. Pract Neurol 2014; 14 (01) 14-22
- 18 Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010; 16 (05) 287-297
- 19 Gorson KC, Ropper AH. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications. Muscle Nerve 2003; 28 (05) 553-560
- 20 Fauchais AL, Magy L, Vidal E. Central and peripheral neurological complications of primary Sjögren's syndrome. Presse Med 2012; 41 (9 Pt 2): e485-e493
- 21 Gemignani F, Marbini A, Pavesi G. et al. Peripheral neuropathy associated with primary Sjögren's syndrome. J Neurol Neurosurg Psychiatry 1994; 57 (08) 983-986
- 22 Ramos-Casals M, Solans R, Rosas J. et al; GEMESS Study Group. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008; 87 (04) 210-219
- 23 Terrier B, Lacroix C, Guillevin L. et al; Club Rhumatismes et Inflammation. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis Rheum 2007; 57 (08) 1520-1529
- 24 Delalande S, de Seze J, Fauchais AL. et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83 (05) 280-291
- 25 Le Guern V, Belin C, Henegar C. et al. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a case-control study. Ann Rheum Dis 2010; 69 (01) 132-137
- 26 Sahoo D, Dash A, Dey A, Devi S. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated longitudinally extensive transverse myelitis (LETM) and primary Sjogren syndrome: a rare association. BMJ Case Rep 2022; 15 (12) e249915
- 27 Jaques CS, de Moraes MPM, Silva EAR. et al. Characterisation of ataxia in Sjogren's syndrome. J Neurol Neurosurg Psychiatry 2020; 91 (04) 446-448
- 28 Anaya JM, Rojas-Villarraga A, Mantilla RD, Arcos-Burgos M, Sarmiento-Monroy JC. Polyautoimmunity in Sjögren Syndrome. Rheum Dis Clin North Am 2016; 42 (03) 457-472
- 29 Theander E, Jacobsson LTH. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 2008; 34 (04) 935-947 , viii–ix viii–ix
- 30 Negrini S, Emmi G, Greco M. et al. Sjögren's syndrome: a systemic autoimmune disease. Clin Exp Med 2022; 22 (01) 9-25
- 31 Rodríguez MF, Asnal C, Gobbi CA. et al. Primary Sjögren syndrome and development of another autoimmune rheumatic disease during the follow-up. Adv Rheumatol 2022; 62 (01) 19
- 32 Afzali AM, Moog P, Kalluri SR. et al. CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype. Front Neurol 2023; 14: 1128315
- 33 Carvalho DC, Tironi TS, Freitas DS, Kleinpaul R, Talim NC, Lana-Peixoto MA. Sjögren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu. Arq Neuropsiquiatr 2014; 72 (08) 619-624
- 34 Akaishi T, Takahashi T, Fujihara K. et al. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. J Neurol 2021; 268 (05) 1938-1944
- 35 Jobling K, Ledingham D, Ng WF, Guadagno J. Positive anti-MOG antibodies in a patient with Sjögren's syndrome and transverse myelitis. Eur J Rheumatol 2018; 6 (02) 102-104
- 36 Pittock SJ, Lennon VA, de Seze J. et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008; 65 (01) 78-83
- 37 Ramos-Casals M, Brito-Zerón P, Bombardieri S. et al; EULAR-Sjögren Syndrome Task Force Group. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Ann Rheum Dis 2020; 79 (01) 3-18
- 38 McCoy SS, Baer AN. Neurological Complications of Sjögren's Syndrome: Diagnosis and Management. Curr Treatm Opt Rheumatol 2017; 3 (04) 275-288
- 39 Vivino FB, Bunya VY, Massaro-Giordano G. et al. Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol 2019; 203: 81-121